Hannon, Tamara S.Rofey, Dana L.Lee, SoJungArslanian, Silva A.2015-09-152015-09-152013-11Hannon, T. S., Rofey, D. L., Lee, S., & Arslanian, S. A. (2013). Depressive Symptoms and Metabolic Markers of Risk for Type 2 Diabetes in Obese Adolescents. Pediatric Diabetes, 14(7), 10.1111/pedi.12035. http://doi.org/10.1111/pedi.12035https://hdl.handle.net/1805/6920OBJECTIVE: Although higher rates of depression are found among individuals with type 2 diabetes, it remains unknown if the presence of depressive symptoms is associated with heightened metabolic risk for the development of type 2 diabetes among youth. The objective of this study was to evaluate whether depressive symptoms in obese adolescents are associated with impaired β-cell function relative to insulin sensitivity [oral disposition index (oDI)] and/or dysglycemia or prediabetes, predictors of type 2 diabetes development. RESEARCH DESIGN AND METHODS: Fasting and oral glucose tolerance test (OGTT)-derived indices of glucose tolerance, insulin sensitivity, secretion, and oDI were evaluated in obese youth (n = 56, age 15.0 ± 1.6 yr, 68% female). The Children's Depression Inventory was utilized to determine depressive symptomatology. RESULTS: Despite no association between depressive symptoms and measures of adiposity, youth with higher depressive symptoms had (i) significantly higher fasting and stimulated glucose levels (13% higher glucose area under the OGTT curve), (ii) ∼50% lower oDI, and (iii) a 50% frequency of prediabetes. CONCLUSIONS: These data point to an important relationship between depressive symptoms and a heightened metabolic risk for type 2 diabetes in obese adolescents, including prediabetes and impairment in β-cell function relative to insulin sensitivity. While the directionality of these relationships is unknown, it should be determined if treating one disorder improves the other or vice versa.en-USPublisher PolicyIGTDepressionInsulin secretionInsulin sensitivityObesityPrediabetesType 2 diabetesArticle